Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area (Cancer (Breast, Lung), Infectious, Neurology, Vaccines), Modality (Small Molecules, Biologics, Biosimilars) - Global Forecast to 2030

icon1
USD 125.95 BN
MARKET SIZE, 2030
icon2
CAGR 8.3%
(2025-2030)
icon3
633
REPORT PAGES
icon4
883
MARKET TABLES

OVERVIEW

contract-research-organization-service-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global contract research organization (CRO) services market is expected to reach USD 125.95 billion in 2030 from USD 84.61 billion in 2025, at a CAGR of 8.3% during the forecast period. Factors such as the increasing complexity & the growing volume of trials; the rising focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs); and the flexibility of services offered by CROs are supporting the growth of this market.

KEY TAKEAWAYS

  • BY REGION
    North America is the largest market, accounting for a share of 44.9% in 2024. The region is home to several prominent CROs. Additionally, the region presence of a well-established pharmaceutical industry, a large number of ongoing clinical trial studies and growing R&D expenditure in the region.
  • BY SERVICE TYPE
    Clinical research services contributed largest share of 57.3% in 2024. This is because Phase I to IV trial execution of clinical trials are the most resource-intensive and cost-driving stage of drug development.
  • BY THERAPEUTIC AREA
    Oncology dominates the market with 35.4% share in 2024. It remains the most innovation-intensive area in drug development, with pipelines expanding and clinical development productivity improving, fueling sustained trial demand.
  • BY END USER
    By end user, the Medical device companies end user is expected to grow at the fastest rate during the forecast period of 2025 to 2030.
  • COMPETITIVE LANDSCAPE
    Major market players have adopted both organic and inorganic strategies, including partnerships and investments. Thermo Fisher Scientific Inc. launched the international CorEvitas Adolescent Alopecia Areata (AA) Registry, addressing a critical unmet need for real-world, adolescent-specific evidence and data related to this autoimmune disease.

The CRO services market is witnessing steady growth, driven by factors such as the increasing complexity & the growing volume of trials; the rising focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs); and the flexibility of services offered by CROs are supporting the growth of this market. Moreover, the upcoming therapeutic drugs patent cliff is fueling pharmaceutical companies to invest heavily in R&D activities and outsource their clinical trials to CROs. Additionally, the growing regulatory focus on patient diversity and data analysis offerings favoring customer reimbursement & market access strategy are other key growth opportunities.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact on biopharma clients’ businesses in the CRO services market arises from evolving sponsor demands and changes in global R&D strategy. Pharmaceutical, biotechnology, medical device, and diagnostics companies are the largest users of CRO solutions, with efficient clinical development and regulatory compliance as primary focus areas. Trends such as increased outsourcing, adoption of decentralized and digital clinical trials, and stricter regulatory requirements now directly affect project timelines, budgets, and commercial launch success for sponsors. 

contract-research-organization-service-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing volume of trials and subsequent rise in complexities.
  • Growing focus on decentralized/patient centric trials
RESTRAINTS
Impact
Level
  • No restraints
OPPORTUNITIES
Impact
Level
  • Increasing regulatory focus on clinical trial diversification
  • Growing adoption of risk-based monitoring
CHALLENGES
Impact
Level
  • Patient retention
  • Cybersecurity and intellectual property challenges

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing volume of trials and subsequent rise in complexities.

The steady rise in global clinical trial volume and increasing protocol complexity are key drivers of CRO market growth. More trials target niche populations in oncology, rare diseases, and cell & gene therapies, requiring specialized expertise and broader geographic reach. Protocol designs demand larger datasets, adaptive methodologies, biomarker integration, and real-world evidence collection, significantly expanding operational demands. These complexities push sponsors to outsource to CROs that can provide global site networks, advanced data analytics, and regulatory alignment. By alleviating the resource and infrastructure burden for sponsors, CROs are positioned as essential partners in accelerating trial execution and ensuring compliance across multiple geographies. As pipelines expand and therapeutic science evolves, the reliance on CRO services is expected to deepen, reinforcing their central role in modern drug development.

Restraint: -

-

Opportunity: Increasing regulatory focus on clinical trial diversification.

Regulatory agencies like the FDA and EMA are increasing requirements for diversity in clinical trials to ensure effective treatments for all populations. The FDA’s 2024 guidelines require trial sponsors to develop Diversity Action Plans (DAPs) to include underrepresented groups, while the EMA’s Clinical Trials Regulation (EU) No. 536/2014 promotes broader participant inclusion. In Europe, the UK HRA/MHRA is piloting Inclusion & Diversity Plans for clinical trials, widening the opportunity for CRO partners with community outreach, decentralized models, and real-world data to deliver on these plans across geographies. In response, CROs are enhancing their offerings, thereby establishing an opportunity for growth during the forecast period.

Challenge: Patient retention.

Patient retention remains a consistent challenge mainly due to burdensome visit schedules, complex protocols, and long study durations. These can derail endpoints. Thus, CROs are building patient-centric programs explicitly to boost engagement and keep participants enrolled. For instance, IQVIA is tackling attrition with digital and in-home support. Its Health Research Space patient app earned a 2025 MedTech Breakthrough Award for engagement, and its Decentralized Trial Suite added Mobile Research Nursing & Phlebotomy to bring visits to the patient, reducing the friction that drives dropouts.

contract-research-organization-service-market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
ICON plc provided clinical trial services to the Pfizer and BioNTech SE investigational COVID-19 vaccine programme. Provided high level of remote clinical monitoring and source data verification, safeguarding data quality and integrity in the evolving pandemic environment
IQVIA collaborated with Janssen Research & Development, LLC on the Phase 3 COVID-19 vaccine clinical trials The client leveraged IQVIA's suite of decentralised trial solutions. Employment of telehealth technologies, virtual oversight, and digital patient engagement strategies

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The CRO services market ecosystem comprises contract research organizations (such as IQVIA, ICON, Syneos Health), specialized service providers (for clinical trials, data management, regulatory affairs), and sponsor clients including pharmaceutical, biotechnology, and medical device companies (like Pfizer, Novartis, and Medtronic). CROs provide essential expertise and infrastructure to design, execute, and manage clinical studies, advancing new therapies from early discovery through regulatory approval. Sponsors rely on CRO partners for cost efficiency, faster timelines, and access to global patient populations, while CROs deliver operational excellence and regulatory compliance. Collaborative partnerships across this value chain are essential for accelerating innovation, lowering development costs, and ensuring success in a highly regulated, competitive life sciences market.

contract-research-organization-service-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

contract-research-organization-service-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

CRO Services Market, By Service Type

As of 2024, clinical research services held the largest share of the CRO services market and will continue leading the market through 2025. The large share of this segment is attributed to the Phase I to IV trial execution of clinical trials being the most resource-intensive and cost-driving stage of drug development. Sponsors increasingly rely on CROs for clinical monitoring, site management, patient recruitment, medical writing, pharmacovigilance, and trial operations to accelerate timelines and meet regulatory demands.

CRO Services Market, By Modality

In 2024, small molecules modality dominated the market The large share of this market can be attributed to factors such as the dominance of the pipeline in terms of volume and the loss of exclusivity of patented products. Additionally, the generics and bioequivalence market adds recurring study volume.

CRO Services Market, By Therapeutic area

In 2024, the oncology therapeutic area is expected to dominate the CRO Services market. Oncology commands the largest share of CRO services because it remains the most innovation-intensive area in drug development, with pipelines expanding and clinical development productivity improving, fueling sustained trial demand.

REGION

Asia Pacific to be fastest-growing region in global CRO services market during forecast period

The Asia Pacific CRO services market is expected to register the highest CAGR during the forecast period, driven by the growth in the pharmaceutical and biopharmaceutical industries, the low cost of conducting clinical trials in the region, the implementation of favorable government policies, and the rising number of CROs in the region.

contract-research-organization-service-market Region

contract-research-organization-service-market: COMPANY EVALUATION MATRIX

In the CRO services market matrix, IQVIA (Star) leads with commanding market share and global operational reach, supported by its advanced data analytics, technology-driven clinical trial solutions, and deep expertise serving top pharmaceutical and biotech sponsors. IQVIA’s integrated offerings and extensive global site network make it the preferred partner for large-scale, multi-regional clinical programs. Medpace (Emerging Leader) is rapidly gaining recognition for its specialized focus in specific therapeutic areas, hands-on project management, and high-touch service model tailored to emerging biotechs and mid-sized pharma clients. Through quality execution and niche expertise, Medpace continues to strengthen its competitive position and expand its footprint in key markets. 

contract-research-organization-service-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 79.10 Billion
Market Forecast in 2030 (Value) USD 125.95 Billion
Growth Rate CAGR of 8.3% from 2025-2030
Years Considered 2023-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Service Type:
    • Clinical Research
    • Early Development
    • Laboratory
    • Consulting
    • And Data Management Services
  • By Therapeutic area:
    • Oncology
    • Infectious Diseases
    • Cardiovascular System Disorders
    • Neurology
    • Vaccines
    • Metabolic Disorders/Endocrinology
    • Immunological Disorders
    • Psychiatry
    • Respiratory Disorders
    • Dermatology
    • Ophthalmology
    • Gastrointestinal Diseases
    • Genitourinary & Women’s Health
    • Hematology (Non-Malignant Hematological Disorders)
    • Other Therapeutic Areas
  • By Modality:
    • Small molecules
    • Biologics
    • Biosimilars
    • Medical devices
  • By End user:
    • Pharmaceutical and biopharmaceutical companies
    • Medical device companies
    • Academic institutes
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa

WHAT IS IN IT FOR YOU: contract-research-organization-service-market REPORT CONTENT GUIDE

contract-research-organization-service-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
CRO Services market analysis for FSP Model
  • Analysis of various segments of the FSP service model
  • Market dynamics affecting FSP services market players
  • Market size estimation and forecast at the regional and country level
  • Optimize FSP portfolio strategy, by geography
  • Identify high-growth accounts, geographies
Quantitative and qualitative analysis (regional level)
  • Clinical Research Services market estimation and forecast at the regional level
  • Qualitative analysis of factors affecting the Clinical research service providers
  • Analysis based on service type, phase, and therapeutic area
  • Prioritize service-line investments
  • Capacity planning by phase and TA
  • Go-to-market strategy and messaging
Partner identification in emerging economies
  • Competitive profiling of North and Latin American CROs
  • Partner identification in emerging economies (Including Asia Pacific)
  • Insights on competitive landscape
  • Decision making related to business expansion efforts
  • Map white spaces for niche differentiation and regional entry

RECENT DEVELOPMENTS

  • August 2025 : IQVIA Inc. and Veeva Systems announced global clinical and commercial partnerships and resolved all pending legal disputes.
  • March 2025 : ICON plc and Mural Health Technologies, Inc. partnered to utilize the participant management and payments platform named Mural Link.
  • January 2024 : Thermo Fisher Scientific Inc. expanded its global laboratory services capability with a new bioanalytical lab in GoCo Health Innovation City in Gothenburg, Sweden, that serves pharmaceutical and biotech customers with advanced laboratory services and instrumentation across all phases of pharmaceutical development.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
53
2
RESEARCH METHODOLOGY
 
 
 
59
3
EXECUTIVE SUMMARY
 
 
 
74
4
PREMIUM INSIGHTS
 
 
 
81
5
MARKET OVERVIEW
Decentralized trials and tech integration drive CRO market growth amidst rising protocol complexity.
 
 
 
88
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
RISING CLINICAL TRIAL VOLUME AND ESCALATING PROTOCOL COMPLEXITY
 
 
 
 
5.2.1.2
GROWING FOCUS ON DECENTRALIZED/PATIENT-CENTRIC TRIALS
 
 
 
 
5.2.1.3
INCREASING PREFERENCE FOR SERVICE FLEXIBILITY
 
 
 
 
5.2.1.4
TECHNOLOGICAL INTEGRATION
 
 
 
 
5.2.1.5
GROWING R&D BUDGETS AND EXPANDING LATE-STAGE PIPELINES
 
 
 
5.2.2
OPPORTUNITIES
 
 
 
 
 
5.2.2.1
SHIFT TOWARD REGULATORY COMPLIANCE
 
 
 
 
5.2.2.2
GROWING ADOPTION OF RISK-BASED MONITORING
 
 
 
 
5.2.2.3
FAVORABLE REIMBURSEMENT SCENARIO
 
 
 
5.2.3
CHALLENGES
 
 
 
 
 
5.2.3.1
PATIENT RETENTION
 
 
 
 
5.2.3.2
CYBERSECURITY AND INTELLECTUAL PROPERTY CHALLENGES
 
6
INDUSTRY TRENDS
Discover how emerging analytics and technologies are redefining pricing and regulatory landscapes globally.
 
 
 
96
 
6.1
MARKET TRENDS
 
 
 
 
 
6.1.1
HEALTH ECONOMICS & OUTCOMES RESEARCH AND REAL-WORLD EVIDENCE
 
 
 
 
6.1.2
IN-SILICO TRIALS
 
 
 
 
6.1.3
SPECIALIZED ANALYTICS FOR EMERGING MODALITIES
 
 
 
6.2
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
6.3
PRICING ANALYSIS
 
 
 
 
 
 
6.3.1
INDICATIVE PRICING ANALYSIS, BY SERVICE TYPE
 
 
 
 
6.3.2
INDICATIVE PRICING ANALYSIS, BY PHASE
 
 
 
 
6.3.3
INDICATIVE PRICING ANALYSIS, BY REGION
 
 
 
6.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
6.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
6.6
INVESTMENT/FUNDING ACTIVITY
 
 
 
 
6.7
TECHNOLOGY ANALYSIS
 
 
 
 
 
6.7.1
KEY TECHNOLOGIES
 
 
 
 
 
6.7.1.1
CLINICAL TRIAL MANAGEMENT SYSTEM
 
 
 
 
6.7.1.2
RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
 
 
 
 
6.7.1.3
ELECTRONIC DATA CAPTURE (EDC) SYSTEM
 
 
 
6.7.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
6.7.2.1
MODEL-INFORMED DRUG DEVELOPMENT
 
 
 
 
6.7.2.2
DATA MANAGEMENT AND INFORMATICS TECHNOLOGIES
 
 
 
6.7.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
6.7.3.1
CLINICAL TRIAL SIMULATION TOOLS
 
 
6.8
KEY CONFERENCES AND EVENTS
 
 
 
 
6.9
REGULATORY LANDSCAPE
 
 
 
 
 
6.9.1
REGULATORY FRAMEWORK
 
 
 
 
 
6.9.1.1
NORTH AMERICA
 
 
 
 
6.9.1.2
EUROPE
 
 
 
 
6.9.1.3
ASIA PACIFIC
 
 
 
 
6.9.1.4
REST OF THE WORLD
 
 
 
6.9.2
REGULATORY ANALYSIS
 
 
 
 
6.9.3
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
6.9.4
REGULATORY SCENARIO FOR DRUG APPROVALS AND CGMP PROCEDURES
 
 
 
6.10
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
6.10.1
BARGAINING POWER OF SUPPLIERS
 
 
 
 
6.10.2
BARGAINING POWER OF BUYERS
 
 
 
 
6.10.3
THREAT OF NEW ENTRANTS
 
 
 
 
6.10.4
THREAT OF SUBSTITUTES
 
 
 
 
6.10.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
6.11
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
6.11.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
6.11.2
BUYING CRITERIA
 
 
 
6.12
CUSTOMER LANDSCAPE
 
 
 
 
 
6.12.1
BUDGET ALLOCATION TREND
 
 
 
 
6.12.2
ADOPTION BARRIER AND INTERNAL FRICTION
 
 
 
6.13
IMPACT OF AI/GEN AI ON CRO SERVICES MARKET
 
 
 
 
 
 
6.13.1
INTRODUCTION
 
 
 
 
6.13.2
MARKET POTENTIAL ACROSS DRUG DEVELOPMENT STAGES
 
 
 
 
6.13.3
AI USE CASES
 
 
 
 
6.13.4
KEY COMPANIES IMPLEMENTING AI
 
 
 
 
6.13.5
FUTURE OF GENERATIVE AI IN DRUG DEVELOPMENT ECOSYSTEM
 
 
 
6.14
IMPACT OF 2025 TRUMP TARIFF ON CRO SERVICES MARKET
 
 
 
 
 
6.14.1
INTRODUCTION
 
 
 
 
6.14.2
KEY TARIFF RATES
 
 
 
 
6.14.3
PRICE IMPACT ANALYSIS
 
 
 
 
6.14.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
6.14.4.1
NORTH AMERICA (US)
 
 
 
 
6.14.4.2
EUROPE
 
 
 
 
6.14.4.3
ASIA PACIFIC
 
 
 
6.14.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
6.14.5.1
PHARMACEUTICAL & BIOTECH COMPANIES
 
 
 
 
6.14.5.2
MEDICAL DEVICE COMPANIES
 
 
 
 
6.14.5.3
ACADEMIC INSTITUTES
 
7
CRO SERVICES MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 164 Data Tables
 
 
 
131
 
7.1
INTRODUCTION
 
 
 
 
7.2
CLINICAL RESEARCH SERVICES
 
 
 
 
 
7.2.1
PHASE III
 
 
 
 
 
7.2.1.1
LARGE-SCALE TESTING ABILITY TO ASSESS EFFICACY AND SAFETY OF DRUGS TO AID GROWTH
 
 
 
7.2.2
PHASE II
 
 
 
 
 
7.2.2.1
GROWING NUMBER OF PIPELINE PRODUCTS IN PHASE II STUDIES TO DRIVE MARKET
 
 
 
7.2.3
PHASE I
 
 
 
 
 
7.2.3.1
ROBUST PIPELINE OF PHARMACEUTICAL AND BIOPHARMACEUTICAL PRODUCTS TO SUPPORT GROWTH
 
 
 
7.2.4
PHASE IV
 
 
 
 
 
7.2.4.1
STRINGENT GLOBAL REGULATIONS FOR DRUG SAFETY MONITORING TO SPUR GROWTH
 
 
7.3
EARLY PHASE DEVELOPMENT SERVICES
 
 
 
 
 
7.3.1
CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES
 
 
 
 
 
7.3.1.1
GROWING NEED TO MEET REGULATORY NORMS FOR DRUGS TO FUEL MARKET
 
 
 
7.3.2
PRECLINICAL SERVICES
 
 
 
 
 
7.3.2.1
PHARMACOKINETICS/PHARMACODYNAMICS
 
 
 
 
7.3.2.2
TOXICOLOGY TESTING
 
 
 
 
7.3.2.3
OTHER PRECLINICAL SERVICES
 
 
 
7.3.3
DISCOVERY STUDIES
 
 
 
 
 
7.3.3.1
INCREASING RELIANCE ON CRO SERVICES FOR TARGET IDENTIFICATION AND VALIDATION TO EXPEDITE GROWTH
 
 
7.4
LABORATORY SERVICES
 
 
 
 
 
7.4.1
ANALYTICAL TESTING
 
 
 
 
 
7.4.1.1
PHYSICAL CHARACTERIZATION
 
 
 
 
7.4.1.2
RAW MATERIAL TESTING
 
 
 
 
7.4.1.3
BATCH-RELEASE TESTING
 
 
 
 
7.4.1.4
STABILITY TESTING
 
 
 
 
7.4.1.5
OTHER ANALYTICAL TESTING SERVICES
 
 
 
7.4.2
BIOANALYTICAL TESTING
 
 
 
 
 
7.4.2.1
INCREASING OUTSOURCING OF R&D ACTIVITIES TO ACCELERATE GROWTH
 
 
7.5
CONSULTING SERVICES
 
 
 
 
 
7.5.1
GROWING ADOPTION OF CONSULTING SERVICES FOR FASTER REGULATORY APPROVALS TO BOOST MARKET
 
 
 
7.6
DATA MANAGEMENT SERVICES
 
 
 
 
 
7.6.1
NEED TO TRACK PROGRESS OF EARLY DRUG DEVELOPMENT TO AUGMENT GROWTH
 
 
8
CRO SERVICES MARKET, BY THERAPEUTIC AREA
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 144 Data Tables
 
 
 
213
 
8.1
INTRODUCTION
 
 
 
 
8.2
ONCOLOGY
 
 
 
 
 
8.2.1
BREAST CANCER
 
 
 
 
 
8.2.1.1
INCREASING CASES AND HIGH SPENDING ON TREATING BREAST CANCER TO SUPPORT GROWTH
 
 
 
8.2.2
LUNG CANCER
 
 
 
 
 
8.2.2.1
INCREASING FOCUS ON DEVELOPING DRUGS AGAINST LUNG CANCER TO FOSTER GROWTH
 
 
 
8.2.3
COLORECTAL CANCER
 
 
 
 
 
8.2.3.1
INCREASING DRUG DISCOVERY AND DEVELOPMENT EFFORTS AGAINST COLORECTAL CANCER TO AID GROWTH
 
 
 
8.2.4
PROSTATE CANCER
 
 
 
 
 
8.2.4.1
GROWING CLINICAL PIPELINE TO PROPEL MARKET
 
 
 
8.2.5
OTHER CANCERS
 
 
 
8.3
INFECTIOUS DISEASES
 
 
 
 
 
8.3.1
INCREASING INCIDENCE OF CHRONIC INFECTIONS TO SUPPORT GROWTH
 
 
 
8.4
CARDIOVASCULAR SYSTEM DISORDERS
 
 
 
 
 
8.4.1
HIGH MORTALITY RATES DUE TO CARDIOVASCULAR DISEASES TO FUEL MARKET
 
 
 
8.5
NEUROLOGY
 
 
 
 
 
8.5.1
GROWING INVESTMENTS IN NEUROLOGICAL DISORDER RESEARCH TO DRIVE MARKET
 
 
 
8.6
VACCINES
 
 
 
 
 
8.6.1
INCREASING FOCUS ON VACCINE DEVELOPMENT TO SPUR GROWTH
 
 
 
8.7
METABOLIC DISORDERS/ENDOCRINOLOGY
 
 
 
 
 
8.7.1
INCREASING GLOBAL DIABETES AND OBESITY POPULATION TO PROMOTE GROWTH
 
 
 
8.8
IMMUNOLOGICAL DISORDERS
 
 
 
 
 
8.8.1
GROWING CLINICAL RESEARCH FOR IMMUNOLOGICAL DISORDERS TO BOOST MARKET
 
 
 
8.9
PSYCHIATRY
 
 
 
 
 
8.9.1
RISING CASES OF PSYCHIATRIC DISORDERS AND DEPRESSION TO SUSTAIN GROWTH
 
 
 
8.10
RESPIRATORY DISORDERS
 
 
 
 
 
8.10.1
RISING INCIDENCE OF CHRONIC RESPIRATORY DISEASE TO FOSTER GROWTH
 
 
 
8.11
DERMATOLOGY
 
 
 
 
 
8.11.1
GROWING FOCUS ON DRUG DEVELOPMENT AGAINST VARIOUS SKIN CONDITIONS TO DRIVE MARKET
 
 
 
8.12
OPHTHALMOLOGY
 
 
 
 
 
8.12.1
GROWTH IN OPHTHALMOLOGY PIPELINE DRUGS TO SUPPORT MARKET
 
 
 
8.13
GASTROINTESTINAL DISEASES
 
 
 
 
 
8.13.1
RAPID LIFESTYLE AND DIETARY CHANGES TO AMPLIFY GROWTH
 
 
 
8.14
GENITOURINARY & WOMEN’S HEALTH
 
 
 
 
 
8.14.1
RISING AWARENESS ABOUT EARLY DISEASE DIAGNOSIS AND TREATMENT TO BOLSTER GROWTH
 
 
 
8.15
HEMATOLOGY
 
 
 
 
 
8.15.1
INCREASING DRUG APPROVALS FOR DRUGS AGAINST NON-MALIGNANT HEMATOLOGICAL CONDITIONS TO SUPPORT GROWTH
 
 
 
8.16
OTHER THERAPEUTIC AREAS
 
 
 
9
CRO SERVICES MARKET, BY MODALITY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 87 Data Tables
 
 
 
287
 
9.1
INTRODUCTION
 
 
 
 
9.2
SMALL MOLECULES
 
 
 
 
 
9.2.1
ONGOING SURGE IN PHARMACEUTICAL R&D INVESTMENTS TO SUPPORT GROWTH
 
 
 
9.3
BIOLOGICS
 
 
 
 
 
9.3.1
MONOCLONAL ANTIBODY
 
 
 
 
 
9.3.1.1
SURGING DEMAND FOR TARGETED THERAPIES ACROSS ONCOLOGY, AUTOIMMUNE DISORDERS, AND INFECTIOUS DISEASES TO DRIVE MARKET
 
 
 
9.3.2
CELL & GENE THERAPY
 
 
 
 
 
9.3.2.1
ROBUST DRUG PIPELINE AND R&D INITIATIVES TO DRIVE MARKET
 
 
 
9.3.3
OTHER BIOLOGICS
 
 
 
9.4
MEDICAL DEVICES
 
 
 
 
 
9.4.1
RAPID INNOVATIONS IN DIAGNOSTICS, IMPLANTABLE, AND DIGITAL HEALTH TECHNOLOGIES TO FOSTER GROWTH
 
 
 
9.5
BIOSIMILARS
 
 
 
 
 
9.5.1
MONOCLONAL ANTIBODY BIOSIMILARS
 
 
 
 
 
9.5.1.1
RISING DEMAND FOR AFFORDABLE THERAPEUTIC OPTIONS TO SUPPORT GROWTH
 
 
 
9.5.2
INSULIN
 
 
 
 
 
9.5.2.1
INCREASING PATENT EXPIRATIONS TO CONTRIBUTE TO GROWTH
 
 
 
9.5.3
COLONY STIMULATING FACTOR
 
 
 
 
 
9.5.3.1
INCREASING USE OF COLONY STIMULATING FACTOR DURING POST-CHEMOTHERAPY TO AID GROWTH
 
 
 
9.5.4
ERYTHROPOEITIN
 
 
 
 
 
9.5.4.1
ESSENTIAL ROLE OF ERYTHROPOIETIN IN TREATING ANEMIA TO STIMULATE GROWTH
 
 
 
9.5.5
OTHER BIOSIMILARS
 
 
10
CRO SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 22 Data Tables
 
 
 
328
 
10.1
INTRODUCTION
 
 
 
 
10.2
PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
 
 
 
 
 
10.2.1
INCREASING OUTSOURCING AND PARTNERSHIPS TO ACCELERATE GROWTH
 
 
 
10.3
MEDICAL DEVICE COMPANIES
 
 
 
 
 
10.3.1
INCREASING RECOGNITION OF CRO PROVIDERS TO AUGMENT GROWTH
 
 
 
10.4
ACADEMIC INSTITUTES
 
 
 
 
 
10.4.1
CONSISTENT COLLABORATIONS BETWEEN CROS AND ACADEMIA TO INTENSIFY GROWTH
 
 
11
CRO SERVICES MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 18 Countries | 347 Data Tables.
 
 
 
342
 
11.1
INTRODUCTION
 
 
 
 
11.2
NORTH AMERICA
 
 
 
 
 
11.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
11.2.2
US
 
 
 
 
 
11.2.2.1
INCREASING INCIDENCE OF ONCOLOGY INDICATIONS TO ACCELERATE GROWTH
 
 
 
11.2.3
CANADA
 
 
 
 
 
11.2.3.1
FAVORABLE GOVERNMENT INITIATIVES AND HIGH INVESTMENTS TO SUPPORT GROWTH
 
 
11.3
EUROPE
 
 
 
 
 
11.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
11.3.2
GERMANY
 
 
 
 
 
11.3.2.1
PRESENCE OF STRONG PHARMACEUTICAL AND BIOTECHNOLOGY R&D INFRASTRUCTURE TO SPUR GROWTH
 
 
 
11.3.3
UK
 
 
 
 
 
11.3.3.1
RISING R&D EXPENDITURE IN PHARMACEUTICAL INDUSTRY TO EXPEDITE GROWTH
 
 
 
11.3.4
FRANCE
 
 
 
 
 
11.3.4.1
INCREASING TECHNOLOGICAL ADVANCEMENTS AND FASTER DRUG DISCOVERY AND DEVELOPMENT INITIATIVES TO AID GROWTH
 
 
 
11.3.5
ITALY
 
 
 
 
 
11.3.5.1
SHORT TIMELINE FOR DRUG APPROVALS TO ENCOURAGE GROWTH
 
 
 
11.3.6
SPAIN
 
 
 
 
 
11.3.6.1
GROWING INVESTMENT IN PHARMACEUTICAL INDUSTRY TO BOOST MARKET
 
 
 
11.3.7
REST OF EUROPE
 
 
 
11.4
ASIA PACIFIC
 
 
 
 
 
11.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
11.4.2
CHINA
 
 
 
 
 
11.4.2.1
CONTINUED EFFORTS ON IMPROVING LEVEL OF DRUG SAFETY AND SUPPLY TO SPUR GROWTH
 
 
 
11.4.3
INDIA
 
 
 
 
 
11.4.3.1
LARGE POOL OF PATIENTS AND PRESENCE OF HIGHLY SKILLED MEDICAL PROFESSIONALS TO AUGMENT GROWTH
 
 
 
11.4.4
JAPAN
 
 
 
 
 
11.4.4.1
GROWING DRUG DEVELOPMENT ACTIVITY TO PROPEL MARKET
 
 
 
11.4.5
AUSTRALIA
 
 
 
 
 
11.4.5.1
GROWING FOCUS ON FUNDING OPPORTUNITIES TO BOOST MARKET
 
 
 
11.4.6
SOUTH KOREA
 
 
 
 
 
11.4.6.1
EMERGING CLINICAL RESEARCH HUB TO SUSTAIN GROWTH
 
 
 
11.4.7
REST OF ASIA PACIFIC
 
 
 
11.5
LATIN AMERICA
 
 
 
 
 
11.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
11.5.2
BRAZIL
 
 
 
 
 
11.5.2.1
GROWING FOCUS ON ENHANCING PHARMACEUTICAL RESEARCH AND PRODUCTION TO FUEL MARKET
 
 
 
11.5.3
MEXICO
 
 
 
 
 
11.5.3.1
INCREASING INVESTMENTS IN PHARMA R&D TO PROMOTE GROWTH
 
 
 
11.5.4
REST OF LATIN AMERICA
 
 
 
11.6
MIDDLE EAST
 
 
 
 
 
11.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST
 
 
 
 
11.6.2
GCC COUNTRIES
 
 
 
 
 
11.6.2.1
KINGDOM OF SAUDI ARABIA (KSA)
 
 
 
 
11.6.2.2
UNITED ARAB EMIRATES (UAE)
 
 
 
 
11.6.2.3
REST OF MIDDLE EAST
 
 
11.7
AFRICA
 
 
 
 
 
11.7.1
BOOMING PHARMACEUTICAL INDUSTRY TO FACILITATE GROWTH
 
 
 
 
11.7.2
MACROECONOMIC OUTLOOK FOR AFRICA
 
 
12
COMPETITIVE LANDSCAPE
Discover top strategies and market positions defining the CRO services competitive landscape.
 
 
 
501
 
12.1
INTRODUCTION
 
 
 
 
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
12.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CRO SERVICES MARKET
 
 
 
12.3
REVENUE ANALYSIS, 2020–2024
 
 
 
 
 
12.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
12.5
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
12.6
BRAND/SERVICE COMPARISON
 
 
 
 
12.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
12.7.1
STARS
 
 
 
 
12.7.2
EMERGING LEADERS
 
 
 
 
12.7.3
PERVASIVE PLAYERS
 
 
 
 
12.7.4
PARTICIPANTS
 
 
 
 
12.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
12.7.5.1
COMPANY FOOTPRINT
 
 
 
 
12.7.5.2
REGION FOOTPRINT
 
 
 
 
12.7.5.3
TYPE FOOTPRINT
 
 
12.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
12.8.1
PROGRESSIVE COMPANIES
 
 
 
 
12.8.2
RESPONSIVE COMPANIES
 
 
 
 
12.8.3
DYNAMIC COMPANIES
 
 
 
 
12.8.4
STARTING BLOCKS
 
 
 
 
12.8.5
COMPETITIVE BENCHMARKING
 
 
 
 
 
12.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
12.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
12.9
COMPETITIVE SCENARIO
 
 
 
 
 
12.9.1
SERVICE/SOLUTION LAUNCHES AND APPROVALS
 
 
 
 
12.9.2
DEALS
 
 
 
 
12.9.3
EXPANSIONS
 
 
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
521
 
13.1
KEY PLAYERS
 
 
 
 
 
13.1.1
IQVIA INC.
 
 
 
 
 
13.1.1.1
BUSINESS OVERVIEW
 
 
 
 
13.1.1.2
SERVICES/SOLUTIONS OFFERED
 
 
 
 
13.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
13.1.1.4
MNM VIEW
 
 
 
13.1.2
ICON PLC
 
 
 
 
13.1.3
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
13.1.4
LABCORP
 
 
 
 
13.1.5
FORTREA, INC.
 
 
 
 
13.1.6
SYNEOS HEALTH
 
 
 
 
13.1.7
WUXI APPTEC
 
 
 
 
13.1.8
CHARLES RIVER LABORATORIES
 
 
 
 
13.1.9
PAREXEL INTERNATIONAL CORPORATION
 
 
 
 
13.1.10
PHARMARON
 
 
 
 
13.1.11
MEDPACE
 
 
 
 
13.1.12
SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA
 
 
 
 
13.1.13
FRONTAGE LABS
 
 
 
 
13.1.14
EUROFINS SCIENTIFIC
 
 
 
 
13.1.15
TIGERMED
 
 
 
 
13.1.16
PSI
 
 
 
 
13.1.17
BIOAGILE THERAPEUTICS PRIVATE LIMITED
 
 
 
 
13.1.18
FIRMA CLINICAL RESEARCH
 
 
 
 
13.1.19
ACCULAB LIFE SCIENCES
 
 
 
 
13.1.20
NOVOTECH
 
 
 
 
13.1.21
LINICAL
 
 
 
 
13.1.22
ADVANCED CLINICAL
 
 
 
13.2
OTHER PLAYERS
 
 
 
 
 
13.2.1
ALLUCENT
 
 
 
 
13.2.2
EMVENIO
 
 
 
 
13.2.3
GUIRES INC.
 
 
 
 
13.2.4
WORLDWIDE CLINICAL TRIALS
 
 
 
 
13.2.5
CTI CLINICAL TRIAL & CONSULTING
 
 
14
APPENDIX
 
 
 
624
 
14.1
DISCUSSION GUIDE
 
 
 
 
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
14.3
CUSTOMIZATION OPTIONS
 
 
 
 
14.4
RELATED REPORTS
 
 
 
 
14.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
CRO SERVICES MARKET: INCLUSIONS AND EXCLUSIONS
 
 
 
 
TABLE 2
IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
 
 
 
 
TABLE 3
CRO SERVICES MARKET: RISK ANALYSIS
 
 
 
 
TABLE 4
CRO SERVICES MARKET: STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
 
 
 
 
TABLE 5
CRO SERVICES MARKET: EMERGING BUSINESS MODELS AND TARGET SEGMENTS
 
 
 
 
TABLE 6
CRO SERVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
 
 
 
 
TABLE 7
INDICATIVE PRICING ANALYSIS, BY SERVICE TYPE, 2024 (USD)
 
 
 
 
TABLE 8
INDICATIVE PRICING ANALYSIS, BY PHASE, 2024 (USD MILLION)
 
 
 
 
TABLE 9
INDICATIVE PRICING ANALYSIS, BY REGION, 2024 (USD MILLION)
 
 
 
 
TABLE 10
CRO SERVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
TABLE 11
CRO SERVICES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
TABLE 12
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 13
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 14
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 15
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 16
CRO SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 17
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY MODALITY
 
 
 
 
TABLE 18
KEY BUYING CRITERIA, BY END USER
 
 
 
 
TABLE 19
CRO SERVICES MARKET: ADOPTION BARRIER AND INTERNAL FRICTION
 
 
 
 
TABLE 20
CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 21
NUMBER OF REGISTERED AND RECRUITING CLINICAL STUDIES AS OF AUGUST 2024, BY LOCATION
 
 
 
 
TABLE 22
CLINICAL RESEARCH SERVICES OFFERED BY MARKET PLAYERS
 
 
 
 
TABLE 23
CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 24
CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 25
NORTH AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 26
EUROPE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 27
ASIA PACIFIC: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 28
LATIN AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 29
MIDDLE EAST: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 30
GCC COUNTRIES: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 31
CRO SERVICES MARKET FOR PHASE III, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 32
NORTH AMERICA: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
EUROPE: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 34
ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 35
LATIN AMERICA: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 36
MIDDLE EAST: CRO SERVICES MARKET FOR PHASE III, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE III, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 38
CRO SERVICES MARKET FOR PHASE II, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
NORTH AMERICA: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 40
EUROPE: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
LATIN AMERICA: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
MIDDLE EAST: CRO SERVICES MARKET FOR PHASE II, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE II, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 45
CRO SERVICES MARKET FOR PHASE I, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
NORTH AMERICA: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
EUROPE: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 48
ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
LATIN AMERICA: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 50
MIDDLE EAST: CRO SERVICES MARKET FOR PHASE I, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE I, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 52
CRO SERVICES MARKET FOR PHASE IV, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 53
NORTH AMERICA: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
EUROPE: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 55
ASIA PACIFIC: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 56
LATIN AMERICA: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
MIDDLE EAST: CRO SERVICES MARKET FOR PHASE IV, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 58
GCC COUNTRIES: CRO SERVICES MARKET FOR PHASE IV, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 60
CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
NORTH AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
EUROPE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 63
ASIA PACIFIC: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 64
LATIN AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
MIDDLE EAST: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 66
GCC COUNTRIES: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 68
NORTH AMERICA: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 69
EUROPE: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 70
ASIA PACIFIC: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 71
LATIN AMERICA: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 72
MIDDLE EAST: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
GCC COUNTRIES: CRO SERVICES MARKET FOR CHEMISTRY, MANUFACTURING, AND CONTROL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 74
CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 75
CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 76
NORTH AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 77
EUROPE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 78
ASIA PACIFIC: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
LATIN AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 80
MIDDLE EAST: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 81
GCC COUNTRIES: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 82
CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 83
NORTH AMERICA: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 84
EUROPE: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 85
ASIA PACIFIC: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 86
LATIN AMERICA: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 87
MIDDLE EAST: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 88
GCC COUNTRIES: CRO SERVICES MARKET FOR PHARMACOKINETICS/PHARMACODYNAMICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 89
CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 90
NORTH AMERICA: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 91
EUROPE: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 92
ASIA PACIFIC: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 93
LATIN AMERICA: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 94
MIDDLE EAST: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
GCC COUNTRIES: CRO SERVICES MARKET FOR TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 96
CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 97
NORTH AMERICA: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 98
EUROPE: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 99
ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 100
LATIN AMERICA: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
MIDDLE EAST: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER PRECLINICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 103
CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 104
NORTH AMERICA: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
EUROPE: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
ASIA PACIFIC: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 107
LATIN AMERICA: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
MIDDLE EAST: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 109
GCC COUNTRIES: CRO SERVICES MARKET FOR DISCOVERY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
LABORATORY SERVICES OFFERED BY KEY PLAYERS
 
 
 
 
TABLE 111
CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
CRO SERVICES MARKET FOR LABORATORY SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
NORTH AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
EUROPE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
ASIA PACIFIC: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
LATIN AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
MIDDLE EAST: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 118
GCC COUNTRIES: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 120
CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
NORTH AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
EUROPE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 123
ASIA PACIFIC: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
LATIN AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
MIDDLE EAST: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
GCC COUNTRIES: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 128
NORTH AMERICA: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
EUROPE: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 130
ASIA PACIFIC: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
LATIN AMERICA: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 132
MIDDLE EAST: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
GCC COUNTRIES: CRO SERVICES MARKET FOR PHYSICAL CHARACTERIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 134
CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
NORTH AMERICA: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
EUROPE: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 137
ASIA PACIFIC: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
LATIN AMERICA: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 139
MIDDLE EAST: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
GCC COUNTRIES: CRO SERVICES MARKET FOR RAW MATERIAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 141
CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
NORTH AMERICA: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 143
EUROPE: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
ASIA PACIFIC: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 145
LATIN AMERICA: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 146
MIDDLE EAST: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 147
GCC COUNTRIES: CRO SERVICES MARKET FOR BATCH-RELEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
CRO SERVICES MARKET FOR STABILITY TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 149
NORTH AMERICA: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 150
EUROPE: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 151
ASIA PACIFIC: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
LATIN AMERICA: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 153
MIDDLE EAST: CRO SERVICES MARKET FOR STABILITY TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 154
GCC COUNTRIES: CRO SERVICES MARKET FOR STABILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 155
CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 156
NORTH AMERICA: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 157
EUROPE: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 158
ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 159
LATIN AMERICA: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 160
MIDDLE EAST: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 161
GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER ANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 162
CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 163
NORTH AMERICA: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 164
EUROPE: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 165
ASIA PACIFIC: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 166
LATIN AMERICA: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 167
MIDDLE EAST: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 168
GCC COUNTRIES: CRO SERVICES MARKET FOR BIOANALYTICAL TESTING, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 169
CONSULTING SERVICES OFFERED BY PROMINENT PLAYERS
 
 
 
 
TABLE 170
CRO SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 171
NORTH AMERICA: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 172
EUROPE: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 173
ASIA PACIFIC: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 174
LATIN AMERICA: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 175
MIDDLE EAST: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 176
GCC COUNTRIES: CRO SERVICES MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 177
CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 178
NORTH AMERICA: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 179
EUROPE: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 180
ASIA PACIFIC: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 181
LATIN AMERICA: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 182
MIDDLE EAST: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 183
GCC COUNTRIES: CRO SERVICES MARKET FOR DATA MANAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 184
CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 185
NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040
 
 
 
 
TABLE 186
CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 187
CRO SERVICES MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 188
NORTH AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 189
EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 190
ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 191
LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 192
MIDDLE EAST: CRO SERVICES MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 193
GCC COUNTRIES: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 194
CRO SERVICES MARKET FOR BREAST CANCER, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 195
NORTH AMERICA: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 196
EUROPE: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 197
ASIA PACIFIC: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 198
LATIN AMERICA: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 199
MIDDLE EAST: CRO SERVICES MARKET FOR BREAST CANCER, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 200
GCC COUNTRIES: CRO SERVICES MARKET FOR BREAST CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 201
CRO SERVICES MARKET FOR LUNG CANCER, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 202
NORTH AMERICA: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 203
EUROPE: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 204
ASIA PACIFIC: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 205
LATIN AMERICA: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 206
MIDDLE EAST: CRO SERVICES MARKET FOR LUNG CANCER, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 207
GCC COUNTRIES: CRO SERVICES MARKET FOR LUNG CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 208
CRO SERVICES MARKET FOR COLORECTAL CANCER, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 209
NORTH AMERICA: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 210
EUROPE: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 211
ASIA PACIFIC: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 212
LATIN AMERICA: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 213
MIDDLE EAST: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 214
GCC COUNTRIES: CRO SERVICES MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 215
CRO SERVICES MARKET FOR PROSTATE CANCER, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 216
NORTH AMERICA: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 217
EUROPE: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 218
ASIA PACIFIC: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 219
LATIN AMERICA: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 220
MIDDLE EAST: CRO SERVICES MARKET FOR PROSTATE CANCER, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 221
GCC COUNTRIES: CRO SERVICES MARKET FOR PROSTATE CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 222
NUMBER OF DRUGS IN R&D PIPELINE FOR OTHER CANCERS, 2023–2024
 
 
 
 
TABLE 223
CRO SERVICES MARKET FOR OTHER CANCERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 224
NORTH AMERICA: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 225
EUROPE: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 226
ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 227
LATIN AMERICA: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 228
MIDDLE EAST: CRO SERVICES MARKET FOR OTHER CANCERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 229
GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER CANCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 230
CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 231
NORTH AMERICA: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 232
EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY INFECTIOUS DISEASES, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 233
ASIA PACIFIC: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 234
LATIN AMERICA: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 235
MIDDLE EAST: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 236
GCC COUNTRIES: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 237
CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 238
NORTH AMERICA: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 239
EUROPE: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 240
ASIA PACIFIC: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 241
LATIN AMERICA: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 242
MIDDLE EAST: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 243
GCC COUNTRIES: CRO SERVICES MARKET FOR CARDIOVASCULAR SYSTEM DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 244
CRO SERVICES MARKET FOR NEUROLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 245
NORTH AMERICA: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 246
EUROPE: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 247
ASIA PACIFIC: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 248
LATIN AMERICA: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 249
MIDDLE EAST: CRO SERVICES MARKET FOR NEUROLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 250
GCC COUNTRIES: CRO SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 251
CRO SERVICES MARKET FOR VACCINES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 252
NORTH AMERICA: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 253
EUROPE: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 254
ASIA PACIFIC: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 255
LATIN AMERICA: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 256
MIDDLE EAST: CRO SERVICES MARKET FOR VACCINES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 257
GCC COUNTRIES: CRO SERVICES MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 258
CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 259
NORTH AMERICA: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 260
EUROPE: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 261
ASIA PACIFIC: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 262
LATIN AMERICA: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 263
MIDDLE EAST: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 264
GCC COUNTRIES: CRO SERVICES MARKET FOR METABOLIC DISORDERS/ENDOCRINOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 265
CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 266
NORTH AMERICA: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 267
EUROPE: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 268
ASIA PACIFIC: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 269
LATIN AMERICA: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 270
MIDDLE EAST: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 271
GCC COUNTRIES: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 272
CRO SERVICES MARKET FOR PSYCHIATRY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 273
NORTH AMERICA: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 274
EUROPE: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 275
ASIA PACIFIC: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 276
LATIN AMERICA: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 277
MIDDLE EAST: CRO SERVICES MARKET FOR PSYCHIATRY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 278
GCC COUNTRIES: CRO SERVICES MARKET FOR PSYCHIATRY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 279
CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 280
NORTH AMERICA: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 281
EUROPE: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 282
ASIA PACIFIC: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 283
LATIN AMERICA: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 284
MIDDLE EAST: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 285
GCC COUNTRIES: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 286
CRO SERVICES MARKET FOR DERMATOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 287
NORTH AMERICA: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 288
EUROPE: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 289
ASIA PACIFIC: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 290
LATIN AMERICA: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 291
MIDDLE EAST: CRO SERVICES MARKET FOR DERMATOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 292
GCC COUNTRIES: CRO SERVICES MARKET FOR DERMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 293
CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 294
NORTH AMERICA: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 295
EUROPE: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 296
ASIA PACIFIC: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 297
LATIN AMERICA: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 298
MIDDLE EAST: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 299
GCC COUNTRIES: CRO SERVICES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 300
CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 301
NORTH AMERICA: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 302
EUROPE: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 303
ASIA PACIFIC: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 304
LATIN AMERICA: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 305
MIDDLE EAST: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 306
GCC COUNTRIES: CRO SERVICES MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 307
CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 308
NORTH AMERICA: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 309
EUROPE: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 310
ASIA PACIFIC: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 311
LATIN AMERICA: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 312
MIDDLE EAST: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 313
GCC COUNTRIES: CRO SERVICES MARKET FOR GENITOURINARY & WOMEN’S HEALTH, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 314
CRO SERVICES MARKET FOR HEMATOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 315
NORTH AMERICA: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 316
EUROPE: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 317
ASIA PACIFIC: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 318
LATIN AMERICA: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 319
MIDDLE EAST: CRO SERVICES MARKET FOR HEMATOLOGY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 320
GCC COUNTRIES: CRO SERVICES MARKET FOR HEMATOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 321
CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 322
NORTH AMERICA: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 323
EUROPE: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 324
ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 325
LATIN AMERICA: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 326
MIDDLE EAST: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 327
GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 328
CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 329
CRO SERVICES MARKET FOR SMALL MOLECULES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 330
NORTH AMERICA: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 331
EUROPE: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 332
ASIA PACIFIC: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 333
LATIN AMERICA: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 334
MIDDLE EAST: CRO SERVICES MARKET FOR SMALL MOLECULES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 335
GCC COUNTRIES: CRO SERVICES MARKET FOR SMALL MOLECULES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 336
CRO SERVICES MARKET FOR BIOLOGICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 337
NORTH AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 338
EUROPE: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 339
ASIA PACIFIC: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 340
LATIN AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 341
MIDDLE EAST: CRO SERVICES MARKET FOR BIOLOGICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 342
GCC COUNTRIES: CRO SERVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 343
CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 344
CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 345
NORTH AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 346
EUROPE: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 347
ASIA PACIFIC: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 348
LATIN AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 349
MIDDLE EAST: CRO SERVICES BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 350
GCC COUNTRIES: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 351
CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 352
NORTH AMERICA: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 353
EUROPE: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 354
ASIA PACIFIC: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 355
LATIN AMERICA: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 356
MIDDLE EAST: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 357
GCC COUNTRIES: CRO SERVICES MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 358
CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 359
NORTH AMERICA: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 360
EUROPE: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 361
ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 362
LATIN AMERICA: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 363
MIDDLE EAST: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 364
GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER BIOLOGICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 365
CRO SERVICES MARKET FOR MEDICAL DEVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 366
NORTH AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 367
EUROPE: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 368
ASIA PACIFIC: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 369
LATIN AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 370
MIDDLE EAST: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 371
GCC COUNTRIES: CRO SERVICES MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 372
CRO SERVICES MARKET FOR BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 373
NORTH AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 374
EUROPE: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 375
ASIA PACIFIC: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 376
LATIN AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 377
MIDDLE EAST: CRO SERVICES MARKET FOR BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 378
GCC COUNTRIES: CRO SERVICES MARKET FOR BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 379
CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 380
CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 381
NORTH AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 382
EUROPE: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 383
ASIA PACIFIC: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 384
LATIN AMERICA: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 385
MIDDLE EAST: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 386
GCC COUNTRIES: CRO SERVICES MARKET FOR MONOCLONAL ANTIBODY BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 387
CRO SERVICES MARKET FOR INSULIN, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 388
NORTH AMERICA: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 389
EUROPE: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 390
ASIA PACIFIC: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 391
LATIN AMERICA: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 392
MIDDLE EAST: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 393
GCC COUNTRIES: CRO SERVICES MARKET FOR INSULIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 394
CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 395
NORTH AMERICA: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 396
EUROPE: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 397
ASIA PACIFIC: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 398
LATIN AMERICA: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 399
MIDDLE EAST: CRO SERVICES MARKET FOR COLONY STIMULATING FACTOR, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 400
GCC COUNTRIES: CRO SERVICES BIOSIMILARS MARKET FOR COLONY STIMULATING FACTOR, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 401
CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 402
NORTH AMERICA: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 403
EUROPE: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 404
ASIA PACIFIC: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 405
LATIN AMERICA: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 406
MIDDLE EAST: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 407
GCC COUNTRIES: CRO SERVICES MARKET FOR ERYTHROPOIETIN, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 408
CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 409
NORTH AMERICA: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 410
EUROPE: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 411
ASIA PACIFIC: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 412
LATIN AMERICA: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 413
MIDDLE EAST: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 414
GCC COUNTRIES: CRO SERVICES MARKET FOR OTHER BIOSIMILARS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 415
CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 416
CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 417
NORTH AMERICA: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 418
EUROPE: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 419
ASIA PACIFIC: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 420
LATIN AMERICA: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 421
MIDDLE EAST: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 422
GCC COUNTRIES: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 423
CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 424
NORTH AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 425
EUROPE: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 426
ASIA PACIFIC: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 427
LATIN AMERICA: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 428
MIDDLE EAST: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 429
GCC COUNTRIES: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 430
CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 431
NORTH AMERICA: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 432
EUROPE: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 433
ASIA PACIFIC: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 434
LATIN AMERICA: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 435
MIDDLE EAST: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 436
GCC COUNTRIES: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 437
CRO SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 438
NORTH AMERICA: CRO SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 439
NORTH AMERICA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 440
NORTH AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 441
NORTH AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 442
NORTH AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 443
NORTH AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 444
NORTH AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 445
NORTH AMERICA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 446
NORTH AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 447
NORTH AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 448
NORTH AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 449
NORTH AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 450
NORTH AMERICA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 451
NORTH AMERICA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 452
US: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 453
US: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 454
US: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 455
US: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 456
US: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 457
US: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 458
US: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 459
US: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 460
US: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 461
US: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 462
US: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 463
US: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 464
CANADA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 465
CANADA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 466
CANADA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 467
CANADA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 468
CANADA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 469
CANADA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 470
CANADA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 471
CANADA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 472
CANADA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 473
CANADA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 474
CANADA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 475
CANADA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 476
EUROPE: CRO SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 477
EUROPE: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 478
EUROPE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 479
EUROPE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 480
EUROPE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 481
EUROPE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 482
EUROPE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 483
EUROPE: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 484
EUROPE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 485
EUROPE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 486
EUROPE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 487
EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 488
EUROPE: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 489
EUROPE: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 490
GERMANY: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 491
GERMANY: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 492
GERMANY: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 493
GERMANY: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 494
GERMANY: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 495
GERMANY: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 496
GERMANY: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 497
GERMANY: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 498
GERMANY: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 499
GERMANY: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 500
GERMANY: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 501
GERMANY: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 502
UK: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 503
UK: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 504
UK: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 505
UK: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 506
UK: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 507
UK: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 508
UK: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 509
UK: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 510
UK: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 511
UK: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 512
UK: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 513
UK: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 514
FRANCE: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 515
FRANCE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 516
FRANCE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 517
FRANCE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 518
FRANCE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 519
FRANCE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 520
FRANCE: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 521
FRANCE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 522
FRANCE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 523
FRANCE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 524
FRANCE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 525
FRANCE: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 526
ITALY: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 527
ITALY: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 528
ITALY: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 529
ITALY: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 530
ITALY: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 531
ITALY: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 532
ITALY: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 533
ITALY: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 534
ITALY: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 535
ITALY: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 536
ITALY: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 537
ITALY: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 538
SPAIN: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 539
SPAIN: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 540
SPAIN: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 541
SPAIN: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 542
SPAIN: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 543
SPAIN: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 544
SPAIN: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 545
SPAIN: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 546
SPAIN: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 547
SPAIN: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 548
SPAIN: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 549
SPAIN: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 550
REST OF EUROPE: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 551
REST OF EUROPE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 552
REST OF EUROPE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 553
REST OF EUROPE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 554
REST OF EUROPE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 555
REST OF EUROPE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 556
REST OF EUROPE: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 557
REST OF EUROPE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 558
REST OF EUROPE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 559
REST OF EUROPE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 560
REST OF EUROPE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 561
REST OF EUROPE: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 562
ASIA PACIFIC: CRO SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 563
ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 564
ASIA PACIFIC: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 565
ASIA PACIFIC: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 566
ASIA PACIFIC: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 567
ASIA PACIFIC: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 568
ASIA PACIFIC: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 569
ASIA PACIFIC: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 570
ASIA PACIFIC: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 571
ASIA PACIFIC: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 572
ASIA PACIFIC: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 573
ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 574
ASIA PACIFIC: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 575
ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 576
CHINA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 577
CHINA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 578
CHINA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 579
CHINA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 580
CHINA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 581
CHINA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 582
CHINA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 583
CHINA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 584
CHINA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 585
CHINA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 586
CHINA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 587
CHINA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 588
INDIA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 589
INDIA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 590
INDIA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 591
INDIA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 592
INDIA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 593
INDIA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 594
INDIA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 595
INDIA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 596
INDIA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 597
INDIA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 598
INDIA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 599
INDIA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 600
JAPAN: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 601
JAPAN: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 602
JAPAN: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 603
JAPAN: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 604
JAPAN: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 605
JAPAN: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 606
JAPAN: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 607
JAPAN: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 608
JAPAN: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 609
JAPAN: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 610
JAPAN: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 611
JAPAN: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 612
AUSTRALIA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 613
AUSTRALIA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 614
AUSTRALIA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 615
AUSTRALIA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 616
AUSTRALIA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 617
AUSTRALIA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 618
AUSTRALIA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 619
AUSTRALIA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 620
AUSTRALIA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 621
AUSTRALIA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 622
AUSTRALIA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 623
AUSTRALIA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 624
SOUTH KOREA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 625
SOUTH KOREA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 626
SOUTH KOREA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 627
SOUTH KOREA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 628
SOUTH KOREA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 629
SOUTH KOREA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 630
SOUTH KOREA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 631
SOUTH KOREA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 632
SOUTH KOREA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 633
SOUTH KOREA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 634
SOUTH KOREA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 635
SOUTH KOREA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 636
REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 637
REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 638
REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 639
REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 640
REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 641
REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 642
REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 643
REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 644
REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 645
REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 646
REST OF ASIA PACIFIC: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 647
REST OF ASIA PACIFIC: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 648
LATIN AMERICA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 649
LATIN AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 650
LATIN AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 651
LATIN AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 652
LATIN AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 653
LATIN AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 654
LATIN AMERICA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 655
LATIN AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 656
LATIN AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 657
LATIN AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 658
LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 659
LATIN AMERICA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 660
LATIN AMERICA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 661
BRAZIL: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 662
BRAZIL: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 663
BRAZIL: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 664
BRAZIL: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 665
BRAZIL: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 666
BRAZIL: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 667
BRAZIL: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 668
BRAZIL: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 669
BRAZIL: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 670
BRAZIL: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 671
BRAZIL: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 672
BRAZIL: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 673
MEXICO: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 674
MEXICO: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 675
MEXICO: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 676
MEXICO: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 677
MEXICO: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 678
MEXICO: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 679
MEXICO: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 680
MEXICO: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 681
MEXICO: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 682
MEXICO: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 683
MEXICO: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 684
MEXICO: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 685
REST OF LATIN AMERICA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 686
REST OF LATIN AMERICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 687
REST OF LATIN AMERICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 688
REST OF LATIN AMERICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 689
REST OF LATIN AMERICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 690
REST OF LATIN AMERICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 691
REST OF LATIN AMERICA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 692
REST OF LATIN AMERICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 693
REST OF LATIN AMERICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 694
REST OF LATIN AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 695
REST OF LATIN AMERICA: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 696
REST OF LATIN AMERICA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 697
MIDDLE EAST: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 698
MIDDLE EAST: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 699
MIDDLE EAST: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 700
MIDDLE EAST: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 701
MIDDLE EAST: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 702
MIDDLE EAST: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 703
MIDDLE EAST: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 704
MIDDLE EAST: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 705
MIDDLE EAST: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 706
MIDDLE EAST: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 707
MIDDLE EAST: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 708
MIDDLE EAST: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 709
MIDDLE EAST: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 710
GCC COUNTRIES: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 711
GCC COUNTRIES: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 712
GCC COUNTRIES: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 713
GCC COUNTRIES: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 714
GCC COUNTRIES: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 715
GCC COUNTRIES: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 716
GCC COUNTRIES: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 717
GCC COUNTRIES: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 718
GCC COUNTRIES: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 719
GCC COUNTRIES: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 720
GCC COUNTRIES: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 721
GCC COUNTRIES: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 722
GCC COUNTRIES: CRO SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 723
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 724
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 725
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 726
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 727
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 728
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 729
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 730
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 731
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 732
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 733
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 734
KINGDOM OF SAUDI ARABIA (KSA): CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 735
UAE: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 736
UAE: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 737
UAE: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 738
UAE: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 739
UAE: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 740
UAE: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 741
UAE: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 742
UAE: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 743
UAE: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 744
UAE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 745
UAE: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 746
UAE: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 747
REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 748
REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 749
REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 750
REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 751
REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 752
REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 753
REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 754
REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 755
REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 756
REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 757
REST OF GCC COUNTRIES: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 758
REST OF GCC COUNTRIES: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 759
REST OF MIDDLE EAST: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 760
REST OF MIDDLE EAST: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 761
REST OF MIDDLE EAST: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 762
REST OF MIDDLE EAST: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 763
REST OF MIDDLE EAST: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 764
REST OF MIDDLE EAST: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 765
REST OF MIDDLE EAST: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 766
REST OF MIDDLE EAST: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 767
REST OF MIDDLE EAST: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 768
REST OF MIDDLE EAST: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 769
REST OF MIDDLE EAST: CRO SERVICES MARKET FOR ONCOLOGY, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 770
REST OF MIDDLE EAST: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 771
AFRICA: CRO SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 772
AFRICA: CRO SERVICES MARKET FOR CLINICAL RESEARCH SERVICES, BY PHASE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 773
AFRICA: CRO SERVICES MARKET FOR EARLY PHASE DEVELOPMENT SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 774
AFRICA: CRO SERVICES MARKET FOR PRECLINICAL SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 775
AFRICA: CRO SERVICES MARKET FOR LABORATORY SERVICES, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 776
AFRICA: CRO SERVICES MARKET FOR ANALYTICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 777
AFRICA: CRO SERVICES MARKET, BY MODALITY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 778
AFRICA: CRO SERVICES MARKET FOR BIOLOGICS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 779
AFRICA: CRO SERVICES MARKET FOR BIOSIMILARS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 780
AFRICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 781
AFRICA: CRO SERVICES MARKET FOR ONCOLOGY MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 782
AFRICA: CRO SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 783
AFRICA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 784
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CRO SERVICES MARKET, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 785
CRO SERVICES MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 786
CRO SERVICES MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 787
CRO SERVICES MARKET: TYPE FOOTPRINT
 
 
 
 
TABLE 788
CRO SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 789
CRO SERVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
TABLE 790
CRO SERVICES MARKET: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 791
CRO SERVICES MARKET: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 792
CRO SERVICES MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 793
IQVIA INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 794
IQVIA INC.: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 795
IQVIA INC.: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 796
IQVIA INC.: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 797
IQVIA INC.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 798
ICON PLC: COMPANY OVERVIEW
 
 
 
 
TABLE 799
ICON PLC: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 800
ICON PLC: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 801
ICON PLC: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 802
ICON PLC: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 803
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 804
THERMO FISHER SCIENTIFIC INC.: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 805
THERMO FISHER SCIENTIFIC, INC.: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 806
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 807
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 808
LABCORP: COMPANY OVERVIEW
 
 
 
 
TABLE 809
LABCORP: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 810
LABCORP: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 811
LABCORP: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 812
LABCORP: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 813
LABCORP: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 814
FORTREA, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 815
FORTREA, INC.: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 816
FORTREA, INC.: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 817
FORTREA, INC.: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 818
FORTREA, INC.: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 819
FORTREA, INC.: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 820
SYNEOS HEALTH: COMPANY OVERVIEW
 
 
 
 
TABLE 821
SYNEOS HEALTH: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 822
SYNEOS HEALTH: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 823
SYNEOS HEALTH: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 824
WUXI APPTEC: COMPANY OVERVIEW
 
 
 
 
TABLE 825
WUXI APPTEC: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 826
WUXI APPTEC: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 827
WUXI APPTEC: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 828
WUXI APPTEC: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 829
CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
 
 
 
 
TABLE 830
CHARLES RIVER LABORATORIES: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 831
CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 832
CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 833
PAREXEL INTERNATIONAL CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 834
PAREXEL INTERNATIONAL CORPORATION: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 835
PAREXEL INTERNATIONAL CORPORATION: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 836
PAREXEL INTERNATIONAL CORPORATION: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 837
PAREXEL INTERNATIONAL CORPORATION: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 838
PHARMARON: COMPANY OVERVIEW
 
 
 
 
TABLE 839
PHARMARON: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 840
MEDPACE: COMPANY OVERVIEW
 
 
 
 
TABLE 841
MEDPACE: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 842
SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA: COMPANY OVERVIEW
 
 
 
 
TABLE 843
SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 844
SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 845
FRONTAGE LABS: COMPANY OVERVIEW
 
 
 
 
TABLE 846
FRONTAGE LABS: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 847
FRONTAGE LABS: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 848
FRONTAGE LABS: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 849
FRONTAGE LABS: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 850
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
TABLE 851
EUROFINS SCIENTIFIC: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 852
EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 853
TIGERMED: COMPANY OVERVIEW
 
 
 
 
TABLE 854
TIGERMED: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 855
TIGERMED: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 856
TIGERMED: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 857
PSI: COMPANY OVERVIEW
 
 
 
 
TABLE 858
PSI: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 859
PSI: SERVICE/SOLUTION LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 860
PSI: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 861
PSI: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 862
BIOAGILE: COMPANY OVERVIEW
 
 
 
 
TABLE 863
BIOAGILE: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 864
FIRMA CLINICAL RESEARCH: COMPANY OVERVIEW
 
 
 
 
TABLE 865
FIRMA CLINICAL RESEARCH: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 866
ACCULAB LIFE SCIENCES: COMPANY OVERVIEW
 
 
 
 
TABLE 867
ACCULAB LIFE SCIENCES: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 868
NOVOTECH: COMPANY OVERVIEW
 
 
 
 
TABLE 869
NOVOTECH: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 870
NOVOTECH: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 871
LINICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 872
LINICAL: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 873
LINICAL: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 874
LINICAL: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 875
ADVANCED CLINICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 876
ADVANCED CLINICAL: SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 877
ADVANCED CLINICAL: DEALS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 878
ADVANCED CLINICAL: EXPANSIONS, JANUARY 2021–AUGUST 2025
 
 
 
 
TABLE 879
ALLUCENT: COMPANY OVERVIEW
 
 
 
 
TABLE 880
EMVENIO: COMPANY OVERVIEW
 
 
 
 
TABLE 881
GUIRES INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 882
WORLDWIDE CLINICAL TRIALS: COMPANY OVERVIEW
 
 
 
 
TABLE 883
CTI CLINICAL TRIAL & CONSULTING: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
CRO SERVICES MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
FIGURE 2
CRO SERVICES MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 3
CRO SERVICES MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
 
 
 
 
FIGURE 4
GLOBAL CRO SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
 
 
 
 
FIGURE 5
GLOBAL CRO SERVICES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
 
 
 
 
FIGURE 6
ILLUSTRATIVE EXAMPLE OF IQVIA INC.: REVENUE SHARE ANALYSIS, 2024
 
 
 
 
FIGURE 7
CRO SERVICES MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
FIGURE 8
CRO SERVICES MARKET: SUPPLY-SIDE AND DEMAND-SIDE ANALYSIS AND TRIANGULATION
 
 
 
 
FIGURE 9
CRO SERVICES MARKET: DEMAND-SIDE ANALYSIS, 2024
 
 
 
 
FIGURE 10
TOP-DOWN APPROACH
 
 
 
 
FIGURE 11
GLOBAL CRO SERVICES MARKET: CAGR PROJECTIONS, 2025–2030
 
 
 
 
FIGURE 12
CRO SERVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
 
 
 
 
FIGURE 13
CRO SERVICES MARKET: DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 14
CRO SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 15
CRO SERVICES MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 16
CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 17
CRO SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 18
REGIONAL SNAPSHOT OF CRO SERVICES MARKET
 
 
 
 
FIGURE 19
INCREASING CLINICAL PIPELINE AND RISING TRIAL VOLUME TO DRIVE MARKET
 
 
 
 
FIGURE 20
US AND SMALL MOLECULES SEGMENT LED NORTH AMERICAN MARKET IN 2024
 
 
 
 
FIGURE 21
CLINICAL RESEARCH SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2024
 
 
 
 
FIGURE 22
PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT DOMINATED MARKET IN 2024
 
 
 
 
FIGURE 23
CHINA TO REGISTER HIGHER CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 24
CRO SERVICES MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 25
ACTIVE PHARMACEUTICAL PIPELINE, 2013–2024
 
 
 
 
FIGURE 26
REVENUE SHIFT AND NEW REVENUE POCKETS FOR CRO SERVICES MARKET
 
 
 
 
FIGURE 27
INDICATIVE PRICING ANALYSIS, BY REGION, 2024 (USD MILLION)
 
 
 
 
FIGURE 28
CRO SERVICES MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 29
CRO SERVICES MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 30
CRO SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 31
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY MODALITY
 
 
 
 
FIGURE 32
KEY BUYING CRITERIA, BY END USER
 
 
 
 
FIGURE 33
DRUGS IN PIPELINE, BY DEVELOPMENT PHASE, 2023 VS. 2024
 
 
 
 
FIGURE 34
PROPORTION OF PIPELINE IN DEVELOPMENT FOR CANCER, 2013–2024
 
 
 
 
FIGURE 35
ESTIMATED NUMBER OF INDIVIDUALS WITH DIABETES, 2000–2045 (MILLION)
 
 
 
 
FIGURE 36
ANNUAL DRUG APPROVALS BY CENTER FOR DRUG EVALUATION AND RESEARCH (FDA), 2012–2024
 
 
 
 
FIGURE 37
R&D SPENDING OF PHRMA MEMBER COMPANIES, 2012–2023
 
 
 
 
FIGURE 38
US FDA DE NOVO MEDICAL DEVICE APPROVALS, 2012–2024
 
 
 
 
FIGURE 39
NORTH AMERICA: CRO SERVICES MARKET SNAPSHOT
 
 
 
 
FIGURE 40
GLOBAL DISTRIBUTION OF R&D COMPANIES, JANUARY 2024 VS. JANUARY 2025
 
 
 
 
FIGURE 41
ASIA PACIFIC: CRO SERVICES MARKET SNAPSHOT
 
 
 
 
FIGURE 42
CRO SERVICES MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024
 
 
 
 
FIGURE 43
MARKET SHARE ANALYSIS OF KEY PLAYERS IN CRO SERVICES MARKET, 2024
 
 
 
 
FIGURE 44
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 45
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 46
CRO SERVICES MARKET: BRAND/SERVICE COMPARISON
 
 
 
 
FIGURE 47
CRO SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 48
CRO SERVICES MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 49
CRO SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 50
IQVIA INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 51
ICON PLC: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 52
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 53
LABCORP: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 54
FORTREA, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 55
WUXI APPTEC: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 56
CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 57
PHARMARON: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 58
MEDPACE: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 59
SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 60
FRONTAGE LABS: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 61
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 62
TIGERMED: COMPANY SNAPSHOT (2024)
 
 
 
 

Methodology

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global CRO services market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The market for companies offering CRO services is arrived at by secondary data available through paid and unpaid sources, analyzing the service portfolios of the leading companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify & collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from market & technology-oriented perspectives. Secondary data was analyzed to arrive at the overall size of the global CRO services market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global CRO services market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and medical device companies, and experts from the supply side, such as C-level and D-level executives, and trial managers. These interviews were conducted across regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (including Latin America, the Middle East, and Africa). This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews. In the complete market engineering process, the top-down & bottom-up approaches were extensively used, along with several data triangulation methods, to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is a breakdown of the primary respondents:

Contract Research Organization (CRO) Services Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down & bottom-up approaches were used to estimate and validate the total size of the CRO services market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up & Top-down Approach

The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process.

Contract Research Organization (CRO) Services Market

Data Triangulation

After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

CROs outsource research services to several pharmaceutical & biotechnology companies, medical device companies, and academic institutes. These services include clinical research, early-phase development, laboratory, consulting, and data management services. A sponsor (i.e., a company investigating the safety and efficacy of new drugs, therapies, or medical devices) partners with a CRO on a contractual or project-by-project basis. The CRO provides advice & guidance for planning, designing, and executing clinical trials; it offers a comprehensive and diverse range of services for each trial phase.

Stakeholders

  • Contract Research Organizations (CROs)
  • Clinical Trial Service Providers
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Manufacturing Companies
  • Academic & Research Institutes
  • Venture Capitalists & Investors
  • Market Research & Consulting Firms
  • Government Associations
  • Medical Institutions & Universities

Report Objectives

  • To define, describe, and forecast the CRO services market based on service type, therapeutic area, modality, end users, and region
  • To provide detailed information regarding the primary factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze the micromarkets concerning individual growth trends, prospects, and contributions to the overall CRO services market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders  
  • To analyze subsegments of the market concerning individual growth trends, prospects, and contributions to the overall market
  • To forecast the revenue of the market segments concerning six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America, the Middle East (GCC and Rest of Middle East), and Africa.
  • To profile the key market players and comprehensively analyze their market shares and core competencies
  • To track & analyze competitive developments such as service launches, agreements, partnerships, acquisitions, business expansions, and research & development activities in the CRO services market.

 

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Contract Research Organization (CRO) Services Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Contract Research Organization (CRO) Services Market

James

Jun, 2022

Which are the driving factors of the contract research organization services market?.

John

Jun, 2022

Who are the major players operating in the contract research organization services market?.

Kahlill

Jun, 2022

Which region will lead the global contract research organization services market?.

DMCA.com Protection Status